Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Tallman
    Tallman
  2. Levine
    Levine
  3. Zelenetz
    Zelenetz
  4. Mauro
    Mauro
  5. Stein
    Stein
  6. Abdel-Wahab
    Abdel-Wahab
  7. Dogan
    Dogan
  8. Horwitz
    Horwitz
  9. Perales
    Perales
  10. Salles
    Salles

Groups

  1. Department of Medicine (295)
  2. Hematologic Malignancies, Division of (294)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)
  7. Executive Committee, Center for Hematologic Malignancies (60)
  8. Hematologic Malignancies Research (45)
  9. Sloan Kettering Institute Postdocs (43)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (41)
Search Within
Formats
  1. Meeting Abstract (178)
  2. Journal Article (122)
  3. Research Letter (26)
  4. Editorial (17)
  5. Review (12)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (295)
  2. Hematologic Malignancies, Division of (294)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Martin Tallman (25)
  3. Andrew Zelenetz (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (17)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (353)
  2. Haematologica Meeting Reports (4)

Results (357)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tyrosine kinase inhibitor (tki) switching: Experience from simplicity, a prospective observational study of chronic-phase chronic myeloid leukemia (cp-cml) patients in clinical practice
    Meeting Abstract

    Hehlmann, R.; Cortes, J.; Gambacorti-Passerini, C.; Goldberg, S. L.; Khoury, H. J.; Mauro, M.; Michallet, M.; Mohamed, H.; Powell, T.; Paquette, R.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Acceleration of BCR-ABL+ leukemia induced by deletion of JAK2
    Meeting Abstract

    Grundschober, E.; Hoelbl-Kovacic, A.; Bhagwat, N.; Levine, R.; Sexl, V.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Effect of idelalisib/rituximab combination treatment of relapsed cll on the bcr signaling-related chemokines ccl3 and ccl4: Data from a phase 3, randomized, double-blind, placebo-controlled trial
    Meeting Abstract

    Ghia, P.; Coutre, S. E.; Furman, R. R.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Symptoms trial update: Symptoms yielded in myelofibrosis patients after transplant as objectified by the mpn-saf tss
    Meeting Abstract

    Geyer, H.; Emanuel, R.; Dueck, A.; Alchaby, H.; Michaelis, L.; Kroger, N.; Giralt, S.; Guptas, V.; Popat, U.; Mesa, R.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • DNA methylation patterns at disease relapse in acute myeloid leukemia target convergent elements and pathways despite inter-patient heterogeneity
    Meeting Abstract

    Garrett-Bakelman, F. E.; Li, S.; Chung, S.; Hricik, T.; Rapaport, F.; Mayden, C.; Bar, H.; Liu, L.; Patel, J.; Sheridan, C.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Treatment with radiation, chemotherapy, or both demonstrates similar outcomes in patients with isolated myeloid sarcoma that may not be different than de novo acute myeloid leukemia
    Meeting Abstract

    Feller, F. M.; Devlin, S. M.; Stein, E. M.; Tallman, M. S.; Rampal, R. K.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Icars: Engineered safety for T cell immunotherapy
    Meeting Abstract

    Fedorov, V.; Themeli, M.; Sadelain, M.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Health-related quality of life impact of idelalisib (idela) in patients with relapsed chronic lymphocytic leukemia (cll): Phase 3 results
    Meeting Abstract

    Eradat, H. A.; Ghia, P.; O'Brien, S. M.; Hillmen, P.; Furman, R. R.; Coutre, S. E.; Sharman, J. P.; Cheson, B. D.; Pagel, J. M.; Barrientos, J. C.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Phase I study of abt-199 (gdc-0199) in patients with relapsed/refractory non-hodgkin lymphoma: Responses observed in diffuse large B-cell (Dlbcl) and follicular lymphoma (FL) at higher cohort doses
    Meeting Abstract

    Davids, M. S.; Seymour, J. F.; Gerecitano, J. F.; Kahl, B. S.; Pagel, J. M.; Wierda, W. G.; Anderson, M.; Rudersdorf, N. K.; Gressick, L. A.; Montalvo, N. P.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed cll
    Meeting Abstract

    Coutre, S. E.; Furman, R. R.; Sharman, J. P.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
    Haematologica (2014)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: